![]() | |
![]() | |
Clinical data | |
---|---|
Trade names | Allegra, FX 24, others[1] |
AHFS/Drugs.com | Monograph |
MedlinePlus | a697035 |
License data |
|
Pregnancy category |
|
Routes of administration | By mouth |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | 30-41%[4] |
Protein binding | 60-70%[5] |
Metabolism | Liver (≤5% of dose)[5] |
Onset of action | < 3 hrs[6] |
Elimination half-life | 14.4 hours |
Duration of action | 12 hrs[6] |
Excretion | Feces (~80%) and urine (~10%) as unchanged drug[5] |
Identifiers | |
| |
Chemical and physical data | |
Formula | C32H39NO4 |
Molar mass | 501.667 g·mol−1 |
3D model (JSmol) | |
Chirality | Racemic mixture |
| |
| |
![]() ![]() |
Fexofenadine, sold under the brand name Allegra among others, is an antihistamine medication used to treat allergy symptoms, such as hay fever and urticaria.[7][8] It is taken by mouth.[6] Effects generally occur within 3 hours and last for about 12 hours.[6]
Common side effects include sleepiness, headache, nausea, and dizziness.[7] Sleepiness is less than with first-generation antihistamines.[6] Other side effects may include allergic reactions.[6] It is classified as a second-generation antihistamine and works as a selective H1-blocker.[6]
Fexofenadine was patented in 1979 and came into medical use in 1996.[9] It has been avaliable as a generic medication since 2011.[10] In the United Kingdom 30 tablets costs the NHS about 2 pounds while this amount costs in the United States about 9 USD as of 2020.[7][11] In 2017, it was the 245th most commonly prescribed medication in the United States, with more than one million prescriptions.[12][13]
References
edit- ^ "Fexofenadine - international brand names". Drugs.com. Archived from the original on 21 April 2021. Retrieved 18 January 2017.
- ^ a b "Fexofenadine Use During Pregnancy". Drugs.com. 1 April 2019. Archived from the original on 26 July 2020. Retrieved 26 July 2020.
- ^ "Fexofenadine hydrochloride 180mg film-coated Tablets - Summary of Product Characteristics (SmPC)". (emc). 26 September 2018. Archived from the original on 26 July 2020. Retrieved 26 July 2020.
- ^ Lappin G, Shishikura Y, Jochemsen R, Weaver RJ, Gesson C, Houston B, Oosterhuis B, Bjerrum OJ, Rowland M, Garner C (May 2010). "Pharmacokinetics of fexofenadine: evaluation of a microdose and assessment of absolute oral bioavailability". Eur J Pharm Sci. 40 (2): 125–31. doi:10.1016/j.ejps.2010.03.009. PMID 20307657.
- ^ a b c Smith, SM; Gums, JG (July 2009). "Fexofenadine: biochemical, pharmacokinetic and pharmacodynamic properties and its unique role in allergic disorders". Expert Opinion on Drug Metabolism & Toxicology. 5 (7): 813–22. doi:10.1517/17425250903044967. PMID 19545214. S2CID 19048690.
- ^ a b c d e f g "Fexofenadine Hydrochloride Monograph for Professionals". Drugs.com. Archived from the original on 14 June 2020. Retrieved 10 November 2020.
- ^ a b c BNF 79 : March 2020. London: Royal Pharmaceutical Society. 2020. p. 288. ISBN 9780857113658.
- ^ Bachert, C (May 2009). "A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis". Clin Ther. 31 (5): 921–44. doi:10.1016/j.clinthera.2009.05.017. PMID 19539095.
- ^ Fischer, Jnos; Ganellin, C. Robin (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 548. ISBN 9783527607495. Archived from the original on 2020-08-13. Retrieved 2020-07-26.
- ^ "Dr. Reddy's announces the launch of Over-the-Counter Fexofenadine HCl and Pseudoephedrine HCl extended release tablets". Dr. Reddy's Laboratories Ltd. 30 August 2011. Archived from the original on 12 October 2016. Retrieved 27 May 2016.
- ^ "Compare Fexofenadine Prices". GoodRx. Archived from the original on 22 April 2020. Retrieved 10 November 2020.
- ^ "The Top 300 of 2020". ClinCalc. Archived from the original on 12 February 2021. Retrieved 11 April 2020.
- ^ "Fexofenadine Hydrochloride - Drug Usage Statistics". ClinCalc. Archived from the original on 8 July 2020. Retrieved 11 April 2020.